Direct conversion of CO to a jet fuel over CoFe alloy catalysts.

The direct conversion of carbon dioxide (CO) using green hydrogen is a sustainable approach to jet fuel production. However, achieving a high level of performance remains a formidable challenge due to the inertness of CO and its low activity for subsequent C-C bond formation. In this study, we prepared a Na-modified CoFe alloy catalyst using layered double-hydroxide precursors that directly transforms CO to a jet fuel composed of C-C jet-fuel-range hydrocarbons with very high selectivity.

An Temperature-Dependent Study of LaO Reactivation Process.

Lanthanum-containing materials are widely used in oxidative catalytic and electrocatalytic reactions such as oxidative coupling of methane (OCM) and solid oxide fuel cells (SOFCs). However, many of these materials are highly susceptible to air contamination which means characterization results generally cannot be associated with their reactivity. In this study, the activation processes of an -prepared bulk LaOCO sample and an as-prepared La(OH) sample are investigated by X-ray photoelectron spectroscopy (XPS), X-ray diffraction (XRD), and online mass spectroscopy (MS).

A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver Disease.

Introduction: The current non-invasive tools for the diagnosis of non-alcoholic fatty liver disease (NAFLD) have methodological limitations. We aimed to develop a non-invasive scale to assist in the diagnosis of NAFLD. To achieve our aim, we conducted a secondary analysis of data from a large observational study conducted in Russia.

Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia.

Objective: Non-alcoholic fatty liver disease (NAFLD) is the most common cause of abnormal results of liver function tests. Earlier research showed that polyenylphosphatidylcholine (PPC) has hepatoprotective effects and thus can be used for the treatment of NAFLD and the prevention of its progression. Accordingly, the aim of this observational study was to evaluate if PPC administered as adjunctive therapy in routine clinical practice can effectively improve liver function tests of NAFLD in Russian patients with associated metabolic comorbidities.

Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study).

Objective: The concept of using naturally occurring compounds such as polyenylphosphatidylcholine (PPC) as an adjunctive therapy to treat non-alcoholic fatty liver disease (NAFLD) and alleviate or reverse hepatic steatosis appears a very attractive option for liver protection. We aim to evaluate if PPC adjunctive therapy can effectively improve the ultrasonographic features of NAFLD in routine clinical practice in Russian patients with cardiometabolic comorbidities.

Design: This 24-week, observational, prospective study was carried out in 174 medical sites across 6 federal districts of Russia.